Seattle Genetics Inc $44.01

up +0.44


29/8/2014 04:00 PM  |  NASDAQ : SGEN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get SGEN Trend Analysis - it has underperformed the S&P 500 by 21%

Partner Headlines

  1. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus
  2. UPDATE: UBS Upgrades Seattle Genetics

    Benzinga
  3. Target And Others Insiders Have Been Buying

    Benzinga
  4. UPDATE: Bank Of America Upgrades Seattle Genetics

    Benzinga
  5. UPDATE: Bank of America Upgrades Seattle Genetics On Trial Risks

    Benzinga
  6. Benzinga's Top Upgrades

    Benzinga
  7. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga
  8. Seattle Genetics Achieves Milestones Under Collaboration with Takeda for ...

    Benzinga
  9. UPDATE: H.C. Wainwright & Co. Initiates Coverage on Seattle Genetics on ...

    Benzinga
  10. UPDATE: Bank of America Reinstates Coverage on Seattle Genetics as High ...

    Benzinga
  11. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  12. Office Depot, Seattle Genetics And Others Insiders Have Been Buying

    Benzinga
  13. Seattle, Genetics Takeda Highlight Long-term Follow-up Data from ADCETRIS ...

    Benzinga
  14. Seattle Genetics Presents Interim Phase 1 from Novel Antibody-Drug Conjugate ...

    Benzinga
  15. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  16. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  17. Seattle Genetics Initiates Phase 1 LIV-1-Positive Metastatic Breast Cancer ...

    Benzinga
  18. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  19. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  20. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  21. Seattle Genetics Commences Two Phase I Trials of SGN-CD19A

    Benzinga
  22. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 2, ...

    GuruFocus
  23. Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial ...

    Benzinga
  24. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,249 ...

    GuruFocus
  25. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,983 Shares

    GuruFocus
  26. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  27. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  28. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  29. Seattle Genetics Offers Data on Next-Gen Antibody-Drug Conjugate SGN-CD33A ...

    Benzinga
  30. Seattle Genetics Presents Encouraging ADCETRIS Data in CD30-Positive Non-Hodgkin ...

    Benzinga
  31. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  32. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 27,327 Shares

    GuruFocus
  33. Seattle Genetics Falls After Q3 Results and Analyst Downgrade

    Benzinga
  34. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  35. Millennium, Seattle Genetics Announce Phase 3 Clinical Trial of ADCETRIS

    Benzinga
  36. Seattle Genetics Announces EC Conditional Marketing Authorization ADCETRIS

    Benzinga
  37. Seattle Genetics Will Get Undisclosed Milestone Payments

    Benzinga
  38. Schaeffer's Quantitative Analyst eyes three stocks with contrarian potential

    SchaeffersResearch
  39. Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN

    GuruFocus
  40. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  41. WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS

    GuruFocus
  42. Seattle Genetics Inc. (SGEN) CFO Todd E Simpson sells 40,000 Shares

    GuruFocus
  43. Health Care Sector Wrap

    FoxBusiness
  44. Exelixis, Universal Display Corporation Among Stocks Up on High Volume ...

    FoxBusiness
  45. Seattle Genetics Inc. Reports Operating Results (10-Q)

    GuruFocus
  46. Seattle Genetics

    IBD
  47. Seattle Genetics Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  48. Seattle Genetics Announces ADCETRIS Receives Positive CHMP Opinion for ...

    Benzinga
  49. Health Care Sector Wrap

    FoxBusiness
  50. Seattle Genetics Inc. (SGEN) President & CEO Clay B Siegall sells 8,25 ...

    GuruFocus
Trading Center